Evidence map›Paper›PMID 35876490›Full record

ArticleMicrobial genomics2022

Replacement of the Alpha variant of SARS-CoV-2 by the Delta variant in Lebanon between April and June 2021.

Georgi Merhi, Alexander J Trotter, Leonardo de Oliveira Martins, Jad Koweyes, Thanh Le-Viet, Hala Abou Naja, Mona Al Buaini, Sophie J Prosolek, Nabil-Fareed Alikhan, Martin Lott and 16 more

Abstract read
In one paragraph

Article in Microbial genomics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Observational
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Challenges of coronavirus disease 2019 (COVID-19) in Lebanon in the midst of the economic collapse.Antimicrobial stewardship & healthcare epidemiology : ASHE · 2022
    Review
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

26 authors.

Georgi MerhiDepartment of Natural Sciences, Lebanese American University, School of Arts and Sciences, Byblos, Lebanon.
Alexander J TrotterQuadram Institute Bioscience, Norwich Research Park, Norwich, Norfolk, UK.
Leonardo de Oliveira MartinsQuadram Institute Bioscience, Norwich Research Park, Norwich, Norfolk, UK.
Jad KoweyesDepartment of Natural Sciences, Lebanese American University, School of Arts and Sciences, Byblos, Lebanon.
Thanh Le-VietQuadram Institute Bioscience, Norwich Research Park, Norwich, Norfolk, UK.
Hala Abou NajaMinistry of Public Health, Epidemiological Surveillance Program, Museum Square, Beirut, Lebanon.
Mona Al BuainiNational Influenza Centre Research Laboratory, Rafic Hariri University Hospital, Beirut, Lebanon.
Sophie J ProsolekQuadram Institute Bioscience, Norwich Research Park, Norwich, Norfolk, UK.
Nabil-Fareed AlikhanQuadram Institute Bioscience, Norwich Research Park, Norwich, Norfolk, UK.
Martin LottQuadram Institute Bioscience, Norwich Research Park, Norwich, Norfolk, UK.
Tatiana TohmehMinistry of Public Health, Epidemiological Surveillance Program, Museum Square, Beirut, Lebanon.
Bassam BadranLaboratory of Molecular Biology and Cancer Immunology, Faculty of Sciences, Lebanese University, Lebanon.
Orla J JuppUniversity of East Anglia, Norwich, Norfolk, UK.
Sarah GardnerUniversity of East Anglia, Norwich, Norfolk, UK.
Matthew W FelgateUniversity of East Anglia, Norwich, Norfolk, UK.
Kate A MakinUniversity of East Anglia, Norwich, Norfolk, UK.
Janine M WilkinsonUniversity of East Anglia, Norwich, Norfolk, UK.
Rachael StanleyNorfolk and Norwich University Hospital, Norwich, Norfolk, UK.
Abdul K SesayMRC Unit The Gambia at LHSTM, Fajara, Gambia.
Mark A WebberQuadram Institute Bioscience, Norwich Research Park, Norwich, Norfolk, UK.
Rose K DavidsonUniversity of East Anglia, Norwich, Norfolk, UK.
Nada GhosnMinistry of Public Health, Epidemiological Surveillance Program, Museum Square, Beirut, Lebanon.
Mark PallenQuadram Institute Bioscience, Norwich Research Park, Norwich, Norfolk, UK.
Hamad HasanMinistry of Public Health, Beirut, Lebanon.
Andrew J PageQuadram Institute Bioscience, Norwich Research Park, Norwich, Norfolk, UK.
Sima TokajianDepartment of Natural Sciences, Lebanese American University, School of Arts and Sciences, Byblos, Lebanon.

Funding

Biotechnology and Biological Sciences Research Council BB/CCG1860/1Biotechnology and Biological Sciences Research Council BB/R012504/1Biotechnology and Biological Sciences Research Council BBS/E/F/000PR10352
6 · The paper itself

Abstract

The COVID-19 pandemic continues to expand globally, with case numbers rising in many areas of the world, including the Eastern Mediterranean Region. Lebanon experienced its largest wave of COVID-19 infections from January to April 2021. Limited genomic surveillance was undertaken, with just 26 SARS-CoV-2 genomes available for this period, nine of which were from travellers from Lebanon detected by other countries. Additional genome sequencing is thus needed to allow surveillance of variants in circulation. In total, 905 SARS-CoV-2 genomes were sequenced using the ARTIC protocol. The genomes were derived from SARS-CoV-2-positive samples, selected retrospectively from the sentinel COVID-19 surveillance network, to capture diversity of location, sampling time, sex, nationality and age. Although 16 PANGO lineages were circulating in Lebanon in January 2021, by February there were just four, with the Alpha variant accounting for 97 % of samples. In the following 2 months, all samples contained the Alpha variant. However, this had changed dramatically by June and July 2021, when all samples belonged to the Delta variant. This study documents a ten-fold increase in the number of SARS-CoV-2 genomes available from Lebanon. The Alpha variant, first detected in the UK, rapidly swept through Lebanon, causing the country's largest wave to date, which peaked in January 2021. The Alpha variant was introduced to Lebanon multiple times despite travel restrictions, but the source of these introductions remains uncertain. The Delta variant was detected in Gambia in travellers from Lebanon in mid-May, suggesting community transmission in Lebanon several weeks before this variant was detected in the country. Prospective sequencing in June/July 2021 showed that the Delta variant had completely replaced the Alpha variant in under 6 weeks.

Indexed as

COVID-19SARS-CoV-2Genome, ViralHumansLebanonPandemicsPhylogenyProspective StudiesRetrospective Studiesbioinformaticsgenomic epidemiologySARS-CoV-2sequencing

Identifiers

PMID35876490
PMCPMC9455693

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.